Episode 36 - Brandon Rice and IND Submission with AI

My guest in this episode is Brandon Rice. Brandon is the CEO and co-founder at Weave Bio, a software company focused on automating regulatory submissions in the pharmaceutical industry using AI where he oversees product development, specifically leading the creation of AutoIND, their AI-powered platform for IND preparation. In this conversation, Brandon discusses his journey to co-founding Weave Bio. He highlights the challenges of regulatory compliance, the potential of AI to streamline processes, and the importance of human oversight in AI-generated content. The discussion also touches on the cultural differences in AI adoption among pharmaceutical companies, global regulatory trends, and the need for open-mindedness towards new technologies. I thoroughly enjoyed my chat with Brandon and learned a lot about the current AI in pharma landscape. I hope you do too. Here's Brandon Rice.

You can listen to Episode 36 - Brandon Rice and IND Submission with AI online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 36 - Brandon Rice and IND Submission with AI is an episode from The Future of Pharma by Samir Gondalia, ISPE Boston.

This episode is 34:47 long.

This episode was published on Sep 17, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Future of Pharma when more episodes are available from the podcast feed.